Currently, Medicare has to wait seven years after a traditional drug gets approved by the U.S. Food and Drug Administration ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices ...

CMS draft expands drug price talks to include Medicare Part B drugs and outlines steps for future renegotiations; public ...

The Department of Health and Human Services today announced it has identified specific pricing targets for pharmaceutical ...

A new analysis looked at estimated out-of-pocket costs for etanercept, ustekinumab, and ibrutinib, specialty drugs that often ...

President Trump recently signed a wide-ranging executive order urging Congress to amend a crucial provision of a Biden-era ...

The Centers for Medicare & Medicaid Services May 12 released draft guidance for the third round of negotiations for the Medicare Drug Price Negotiation Program. The guidance includes policies ...

President Donald Trump signed an executive order Monday aiming to significantly reduce prescription drug prices in the United ...